Skip to main content
. Author manuscript; available in PMC: 2009 Jun 24.
Published in final edited form as: Vaccine. 2007 Jun 26;25(33):6158–6163. doi: 10.1016/j.vaccine.2007.06.012

Table 2.

Clinical status of rabbits prior to vaccination three weeks after CRPV infection

Papilloma variable Status at sites infected with the following CRPV dilutions:

Group a 1:50 1:1000 or 1:4000
Frequency b
1 9 / 9 16 / 18
2 9 / 9 14 / 18
Volume c
1 0.28 ± 0.17 0.04 ± 0.01
2 0.19 ± 0.07 0.09 ± 0.03
a

The rabbits were subsequently treated as controls (group 1) or vaccinees (group 2). Each group contained three rabbits.

b

Number of papilloma-forming sites/total number of infected sites.

c

Actual volume in cubic millimeters (mean ± SEM)